Get the Stockscreener App
35.40
2.93%
-1.07
Pre-market:
33.01
-2.39
-6.75%
Sanara Medtech Inc stock is traded at $35.40, with a volume of 12,334.
It is down -2.93% in the last 24 hours and up +4.70% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$36.47
Open:
$36.6
24h Volume:
12,334
Relative Volume:
0.41
Market Cap:
$309.44M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-68.08
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
-3.91%
1M Performance:
+4.70%
6M Performance:
+27.61%
1Y Performance:
-3.28%
1-Day Range:
$35.08
$36.60
1-Week Range:
$35.00
$37.36
52-Week Range:
$26.00
$40.75
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
35.40 | 309.44M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Fifth Third Bancorp Makes New Investment in Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M - MSN
Sanara MedTech: A Promising Growth Story At An Attractive Valuation - Seeking Alpha
(SMTI) Investment Report - Stock Traders Daily
Cantor Fitzgerald Estimates Sanara MedTech FY2024 Earnings - Defense World
FY2024 EPS Estimate for Sanara MedTech Increased by Analyst - Defense World
FY2024 EPS Estimates for Sanara MedTech Increased by Analyst - MarketBeat
HC Wainwright Forecasts Stronger Earnings for Sanara MedTech - MarketBeat
Sanara MedTech’s (SMTI) Buy Rating Reiterated at HC Wainwright - Defense World
Sanara MedTech Inc. Announces the Commercial Launch of Two New Innovative Extracellular Matrix Products from Cook Biotech Inc. - ACCESS Newswire
Sanara MedTech Inc. Announces the Execution of a New License Agreement with Rochal Industries, LLC - ACCESS Newswire
Financial Comparison: Sanara MedTech (NASDAQ:SMTI) vs. ReWalk Robotics (NASDAQ:LFWD) - Defense World
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. - The Manila Times
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, - GlobeNewswire
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution… - Informazione.it
Cantor Fitzgerald Comments on Sanara MedTech FY2025 Earnings - Defense World
Cantor Fitzgerald Estimates Sanara MedTech FY2025 Earnings - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Insiders were the key beneficiaries as Sanara MedTech Inc.'s (NASDAQ:SMTI) market cap rises to US$297m - Simply Wall St
Sanara MedTech expands executive leadership team - Medical Buyer
Barclays PLC Has $174,000 Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech Inc. Posts Strong Growth in Q4 and Full Year 2024 Results - Defense World
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Defense World
Sanara MedTech Strengthens Leadership with New CFO Appointment - TipRanks
Sanara MedTech Secures U.S. Rights for OsStic - TipRanks
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight By Investing.com - Investing.com South Africa
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight - Investing.com
Cantor Fitzgerald Reiterates Overweight Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara MedTech expects Q4 revenue to increase 45%- 48% - Medical Buyer
SMTISanara MedTech Inc. Latest Stock News & Market Updates - StockTitan
Sanara MedTech reshapes executive team with new CFO and CAO - MSN
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 - The Manila Times
Sanara MedTech reshapes executive team with new CFO and CAO By Investing.com - Investing.com Canada
Sanara MedTech Inc. Announces Exclusive License and - GlobeNewswire
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments - GlobeNewswire
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Announces the Execution of an Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Appoints Michael McNeil as Chief Accounting Officer and Chief Administrative Officer - Marketscreener.com
Sanara MedTech Reports Record Q4: Revenue Surges 48% on Strong Surgical Product Sales - StockTitan
How to Take Advantage of moves in (SMTI) - Stock Traders Daily
Barclays PLC Acquires 4,376 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Geode Capital Management LLC Grows Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
How the (SMTI) price action is used to our Advantage - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) Stake Boosted by State Street Corp - Defense World
HC Wainwright Comments on Sanara MedTech FY2024 Earnings - Defense World
Analysts Issue Forecasts for Sanara MedTech FY2024 Earnings - MarketBeat
H.C. Wainwright gives Sanara MedTech a Buy rating as market penetration strategy pays off - Investing.com Nigeria
Sanara MedTech (NASDAQ:SMTI) Now Covered by Analysts at HC Wainwright - Defense World
H.C. Wainwright gives Sanara MedTech a Buy rating as market penetration strategy pays off By Investing.com - Investing.com South Africa
HC Wainwright & Co. Initiates Coverage of Sanara MedTech (SMTI) with Buy Recommendation - MSN
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):